Shanghai Lingyue Biomedical Technology

Shanghai Lingyue Biomedical Technology is a biotechnology company focused on the development of exosome-based therapeutics and diagnostics. Established in 2018, the company leverages a proprietary platform for the large-scale isolation and engineering of exosomes to serve as targeted delivery vehicles for various payloads, including nucleic acids and proteins. Their research and development efforts primarily target oncology, inflammatory disorders, and regenerative medicine. Additionally, Lingyue provides high-quality exosome research tools and services to academic and industrial partners globally. The company's platform aims to overcome traditional drug delivery challenges by utilizing the natural biocompatibility and targeting capabilities of extracellular vesicles.